Baird Medical Charts 2025 Strategic Vision Following Milestone Year

BDMD 12.10.2024

Full Press ReleaseSEC FilingsOur BDMD Tweets

About Gravity Analytica

Recent News

  • 01.22.2025 - Baird Medical Expands into San Francisco, Advancing U.S. Market Growth
  • 01.21.2025 - Dr. Emad Kandil Achieves Milestone of 100 Microwave Ablation Cases in Thyroid Care
  • 01.17.2025 - Baird Medical Engages with Healthcare Leaders Amid 2025 J.P. Morgan Healthcare Conference

Recent Filings

  • 01.17.2025 - F-1/A Registration statement for certain foreign private issuers
  • 01.10.2025 - S-8 Securities to be offered to employees in employee benefit plans

NEW YORK,Dec. 10, 2024/PRNewswire/ -- Baird Medical Group (NASDAQ: BDMD), a leader in minimally invasive medical technologies, recently convened its 2024 Annual Review and 2025 Planning Meeting at theBaird Capital TowerinGuangzhou, China. The two-day event brought together executives, production leaders, and regional managers to reflect on the company's achievements and plan for the year ahead.

2024 Annual Review and 2025 Planning Meeting

On the first day, company leaders participated in the 7thThyroid Disease ForuminGuangzhou, gaining insights into the latest advancements in thyroid treatment. These insights will inform marketing strategies and R&D initiatives in the coming year. Following the forum, leaders reviewed 2024 performance, highlighting market growth, innovations, and areas for improvement. Regional sales managers presented market reports and sales plans for 2025, setting a strong foundation for the upcoming year.

On the second day, Production Manager Le Zhang shared updates on product development progress and the 2025 production schedule, including plans to enhance after-sales service. Executives and managers discussed strategies to strengthen distributor relationships, ensuring alignment with Baird Medical's global expansion goals.

In 2024, Baird Medical's NASDAQ listing expanded its international recognition, positioning the company for further success in minimally invasive medical technologies. As the company enters 2025, Baird Medical remains committed to advancing in this field, confident in the team's ability to drive innovation, achieve growth, and successfully execute its strategic vision for the year ahead.

About Baird MedicalBaird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visithttps://bairdmed.com/

Baird Medical (PRNewsfoto/Baird Medical LLC)

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-charts-2025-strategic-vision-following-milestone-year-302326993.html

SOURCE BDMD

Eric Huang, PR Liaison, Baird Medical LLC, +1 (888) 508-6228, erichuang@bairdmed.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com